Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Depreciation & Amortization (CF) for 8 consecutive years, with $377000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 16.22% to $377000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 53.34% year-over-year, with the annual reading at $1.5 million for FY2025, 55.88% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $377000.0 at Precision Biosciences, up from $309000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $2.4 million in Q2 2021, with the low at $309000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $1.4 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Depreciation & Amortization (CF) grew 7.4% in 2021, then tumbled 65.44% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $2.2 million in 2021, then fell by 9.89% to $2.0 million in 2022, then plummeted by 34.74% to $1.3 million in 2023, then plummeted by 64.82% to $450000.0 in 2024, then dropped by 16.22% to $377000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $377000.0, $309000.0, and $330000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.